Ct7 (MAGE-CI) antigen expression in normal and neoplastic tissues

被引:54
作者
Jungbluth, AA
Chen, YT
Busam, KJ
Coplan, K
Kolb, D
Iversen, K
Williamson, B
van Landeghem, FKH
Stockert, E
Old, LJ
机构
[1] Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res, New York, NY 10021 USA
[2] Cornell Univ, Coll Med, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[4] Charite Med Ctr, Inst Neuropathol, Berlin, Germany
关键词
CT7; MAGE-CI; heterogeneous antigen expression; monoclonal antibody CT7-33;
D O I
10.1002/ijc.10416
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CT7 (MAGE-C1) is a member of the cancer testis (CT) antigen family. The present study describes the generation of CT7-33, a monoclonal antibody (MAb) to CT7, and the preliminary protein expression analysis of CT7 in normal tissues and in a limited number of neoplastic lesions. CT7-33 was effective in frozen as well as formalin-fixed, paraffin-embedded tissues, and immunohistochemistry/reverse transcriptase polymerase chain reaction (RT-PCR) co-typing demonstrated antibody specificity. CT7-33 immunoreactivity in normal adult tissues is restricted to testicular germ cells. In neoplastic lesions, CT7-33 immunostaining is confined to tumor cells, and the frequency of CT7 protein expression mostly parallels previous mRNA analyses. Whereas colorectal and renal cell carcinomas, as well as sarcomas, exhibit poor or no CT7-33 staining, carcinomas of the mammary gland and ovary, nonsmall cell lung carcinoma and metastatic melanomas exhibit a high incidence of CT7 protein expression. However, as seen in previous analyses of other CT antigens, the expression pattern is mostly heterogeneous, and tumors with more than 50% of tumor staining are only infrequently encountered. In summary, our study presents a new serologic reagent for the analysis of CT7 on a protein level and confirms what is known with regard to the expression pattern of other CT antigens in tumors: frequent heterogeneity of antigen expression. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:839 / 845
页数:7
相关论文
共 32 条
[1]   Tumor antigens [J].
Boon, T ;
Old, LJ .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (05) :681-683
[2]   Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library [J].
Chen, YT ;
Güre, AO ;
Tsang, S ;
Stockert, E ;
Jäger, E ;
Knuth, A ;
Old, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) :6919-6923
[3]   IMMUNOPHENOTYPING OF MELANOMAS FOR TYROSINASE - IMPLICATIONS FOR VACCINE DEVELOPMENT [J].
CHEN, YT ;
STOCKERT, E ;
TSANG, S ;
COPLAN, KA ;
OLD, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) :8125-8129
[4]   Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas [J].
Chen, YT ;
Stockert, E ;
Jungbluth, A ;
Tsang, SL ;
Coplan, KA ;
Scanlan, MJ ;
Old, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :5915-5919
[5]   IDENTIFICATION OF THE MAGE-1 GENE-PRODUCT BY MONOCLONAL AND POLYCLONAL ANTIBODIES [J].
CHEN, YT ;
STOCKERT, E ;
CHEN, Y ;
GARINCHESA, P ;
RETTIG, WJ ;
VANDERBRUGGEN, P ;
BOON, T ;
OLD, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (03) :1004-1008
[6]   A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening [J].
Chen, YT ;
Scanlan, MJ ;
Sahin, U ;
Tureci, O ;
Gure, AO ;
Tsang, SL ;
Williamson, B ;
Stockert, E ;
Pfreundschuh, M ;
Old, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) :1914-1918
[7]  
Cheville JC, 1999, MODERN PATHOL, V12, P974
[8]   Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes [J].
DePlaen, E ;
Lurquin, C ;
Lethe, B ;
vanderBruggen, P ;
Brichard, V ;
Renauld, JC ;
Coulie, P ;
VanPel, A ;
Boon, T .
METHODS, 1997, 12 (02) :125-142
[9]  
Fischer C, 1997, INT J CANCER, V71, P1119, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1119::AID-IJC34>3.0.CO
[10]  
2-5